Joe Flanagan
Chief Business OfficerMr. Joe Flanagan serves as Chief Business Officer of Accustem Sciences, Inc. since March 2022 and also serves as Chief Business Officer of AccuStem Sciences Limited since January 2022. He has sales excellence experience and is one of the most sought-after talents in Oncology. He is a strategic expert, playing a leading role in the commercial development and successful launch of several product offerings from early-stage diagnostic startups to large pharmaceutical companies. Prior to joining Accustem, he served as the VP of Sales for Precision Therapeutics as well as the VP of Market Development for Biodesix and Agendia. From July 2018 to July 2019, he was Vice President of Sales for Circulogene. During his tenure, record revenues were realized as a result of his efforts to enhance the clinical agility and logistical focus of each company’s sales team. Most recently, he led strategic development efforts with Ambry Genetics’ Oncology franchise.
Positions
- Company NameAccuStem Sciences, Inc.Stock CodeACUTPositionChief Business Officer
